{"entity":{"id":"protein-toxin-payloads","kind":"term","name":"Protein toxin payloads and immunotoxins","aka":["ribosome-inactivating protein payloads","deBouganin","bouganin conjugates"],"tldr":"An antibody can deliver a protein toxin that stops a cell making proteins. These larger payloads belong to the related field of immunotoxins and need different delivery and safety studies.","summary":"DeBouganin is a modified ribosome-inactivating protein. A primary study tested trastuzumab-deBouganin conjugates and an antibody-fragment fusion protein in cells resistant to tubulin-payload conjugates. Both chemical conjugation and fusion-protein delivery were examined. These protein toxins are different from small-molecule degraders such as GSPT1 payloads and from conventional chemotherapy payloads. The cited cellular results do not establish clinical activity after antibody-drug conjugate treatment.","asOf":"2026-11-08","links":[{"label":"DeBouganin conjugates and fusion proteins in resistant cells (2016)","url":"https://doi.org/10.3390/molecules21121741"}],"tags":[],"related":[],"cancers":[],"sections":[],"technologies":["adc"],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":["payload"],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"category":"ADC chemistry"},"route":"/terms/protein-toxin-payloads/","neighbours":{"technology":[{"id":"adc","kind":"technology","name":"Antibody-drug conjugate (ADC)","route":"/technologies/adc/"}],"term":[{"id":"next-generation-adc-payloads","kind":"term","name":"Next-generation antibody-conjugate payloads","route":"/terms/next-generation-adc-payloads/"},{"id":"payload","kind":"term","name":"Payload (ADC)","route":"/terms/payload/"}]}}